Verzögert
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
3’148 JPY | +1.38% | -0.13% | +8.31% |
30.04. | Otsuka Holdings' zurechenbarer Gewinn springt um 26% in Q1 | MT |
09.04. | H. Lundbeck und Otsuka Pharmaceutical beantragen US FDA-Zulassung für PTSD-Kombinationstherapie | MT |
ETFs investiert in Otsuka Corporation
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
0,54% | 19 M€ | +4.94% | ||
0,30% | 29 M€ | +8.37% | - | |
0,22% | 267 M€ | +6.08% | ||
0,20% | 60 M€ | +16.25% | ||
0,18% | 26 M€ | +21.93% | ||
0,17% | 11 M€ | +13.64% | - | |
0,17% | 4 M€ | +16.82% | ||
0,16% | 73 M€ | +16.75% | ||
0,13% | 10 207 M€ | +17.01% | ||
0,13% | 5 115 M€ | +16.46% | ||
0,10% | 18 M€ | +16.15% | - | |
0,09% | 66 066 M€ | +17.14% | - | |
0,09% | 144 586 M€ | +16.91% | ||
0,09% | 20 721 M€ | +15.97% | - | |
0,03% | 10 M€ | -3.35% | - | |
0,02% | 1 120 M€ | -0.11% | ||
0,02% | 7 M€ | +1.36% | - | |
0,01% | 277 M€ | -.--% | - | |
0,01% | 441 M€ | +9.46% | ||
0,01% | 194 M€ | +7.54% | - | |
0,01% | 31 M€ | +2.75% | - | |
0,01% | 786 M€ | -.--% | ||
0,01% | 23 M€ | -.--% | - | |
0,01% | 206 M€ | -.--% | ||
0,01% | 607 M€ | +0.05% | - | |
0,01% | 1 166 M€ | +0.26% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+8.31% | 7.51 Mrd. | |
-8.75% | 31.67 Mrd. | |
+1.28% | 15.31 Mrd. | |
-5.82% | 8.93 Mrd. | |
+2.93% | 4.95 Mrd. | |
-45.08% | 4.54 Mrd. | |
+12.57% | 3 Mrd. | |
+10.17% | 2.45 Mrd. | |
-11.35% | 2.44 Mrd. | |
-12.49% | 2.17 Mrd. |
- Börse
- Aktien
- 502503 Aktie
- ETFs Otsuka Corporation